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RACISM AND HEALTH CARE IN AMERICA: 
LEGAL RESPONSES TO RACIAL 
DISPARITIES IN THE ALLOCATION OF 
KIDNEYS 
CARA A FAUCI* 
Abstract: African Americans have long been subjected to racism within 
the health care sector of the United States. During earlier eras of 
American history, including the pre-Civil War, Reconstruction and Jim 
Crow time periods, blatant racism in the health care sector was 
prevalent. Following the Civil Rights Movement of the 1960s, more overt 
forms of racism dissipated. Now, at the dawn of the twenty-first century, 
racism within the health care industry manifests itself in more subtle 
forms. A modern day example of the abominable and often 
governmentally sanctioned health care that African Americans receive is 
racial discrimination in the allocation of transplantable kidneys. Despite 
having a greater incidence of kidney failure than European Americans, 
African Americans are less likely to be the recipients of transplantable 
kidneys and spend considerably longer periods of time on kidney 
allocation waiting lists than European Americans. This Note proposes 
and analyzes various responses to disparities in kidney allocation on the 
basis of race including public education, organ donation publicity 
campaigns, presumed consent to donation laws, the creation of criteria 
for placement on an United Network for Organ Sharing kidney 
allocation waiting list, alteration of kidney allocation guidelines, and 
litigation under both the Equal Protection Clause of the United States 
Constitution and Title VI of the Civil Rights of 1964. 
INTRODUCTION 
The health care sector of American society is far from immune to 
social injustice and the various forms of inequality that negatively im-
pact other societal systems) The United States health care industry 
has been and continues to be plagued by racism.2 During the pre-Civil 
* Solicitations Editor, BOSTON COLLEGE THIRD WORLD LAw JOURNAL (2000-2001). 
1 Seediscussion infra Part I.C and notes 58-127. 
2 See discussion infra Part I and notes 16-127. 
35 
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War, Reconstruction and Jim Crow eras of American history, overt ra-
cism within the medical sphere was common.3 Mter the Civil Rights 
Movement of the 1960s, segregation and some of the more blatant 
manifestations of racism dissipated.4 More subtle forms of racism, 
however, continue to pervade the health care industry.5 
A modern-day example of the abominable and often governmen-
tally sanctioned health care that Mrican Americans have historically 
received is racial discrimination in the allocation of kidneys for trans-
plantation.6 Statistical data reflects sharp disparities in kidney alloca-
tion on the basis of race.' This Note addresses the issue of racial dis-
parity in the allocation of transplantable kidneys and offers possible 
legal solutions to this problem. 
Part I of this Note provides the reader with an overview of race 
discrimination within the American health care system.s It outlines 
racism in health care during various historical periods such as the pre-
Civil War, Reconstruction and Jim Crow eras.9 Additionally, it 
identifies present-day racial inequalities within the health care indus-
try.lO Part II offers brief background information on the kidney, kid-
ney disease, and medical responses to kidney failure such as hemodi-
alysis and kidney transplantation.ll It also explains governmental 
regulation of organ allocation, thereby establishing the government's 
role in this form of racial discrimination.12 
Part III provides empirical evidence pertaining to racial dispari-
ties in kidney allocation and offers possible explanations for this ine-
quality.13 Part IV proposes and analyzes legal and non-legal responses 
to racial disparities in the allocation of kidneys.14 This Note concludes 
that a multifaceted approach inclusive of public education, organ do-
nation publicity campaigns, "presumed consent" laws, alteration of 
kidney allocation guidelines, creation of placement criteria for kidney 
3 See discussion infra Parts I.A-B and notes 16-57. 
4 See discussion infra Part I.e and notes 58-127. 
5 See discussion infra Part I.e and notes 58-127. 
6 See discussion infi'a Part III.A and notes 180-194. 
7 See discussion infra Part I1I.A and notes 180-194. 
8 See discussion infi'a Part I and notes 16-127. 
9 Seediscussion infi'a Parts I.A-B and notes 16-57. 
10 See discussion infra Part I.e and notes 58-127. 
11 See discussion infra Part II.A and notes 128-165. 
12 Seediscussion infra Part II.B and notes 166-179. 
13 See discussion infra Part III and notes 180-213. 
14 See discussion infra Part IV and notes 214-297. 
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allocation waiting lists, and Title VI litigation has the ability to bring 
about greater racial parity in the allocation of transplantable kid-
neys.I5 
I. HISTORICAL OVERVIEW OF RACIAL DISCRIMINATION IN HEALTH 
CARE: PRE-CIVIL WAR TO PRESENT DAY 
A. Pre-Civil War and Reconstruction 
Mrican Americans have long been victims of discrimination in 
the health care sector of American society.16 Prior to the Civil War and 
the abolition of slavery in the United States, almost all Mrican Ameri-
cans were dependent upon their masters for healthcare,l7 Some slave-
holders felt that they had a direct financial interest in the physical 
well-being of their slaves and thus provided health care to those who 
worked on their plantations. IS During the era of slavery, it was not un-
common for plantations to have their own hospitals staffed by Mrican-
American women considered knowledgeable on the topics of illness 
and healing.19 Other plantation owners formed contracts with local 
physicians to provide health care for their slaves.2o Despite the avail-
ability of health care, however, the quality of treatment that Mrican 
Americans tended to receive was below the quality of care provided to 
Americans of European lineage.21 For instance, European-American 
physicians who contracted with plantation owners on a yearly basis 
tended to provide the minimum amount of care required.22 
15 See discussion infra Part I.C and notes 58-127. 
16 See DAVID BARTON SMITH, HEALTH CARE DIVIDED: RACE AND HEALING A NATION 3-
31 (1999); Barbara L. Bernier, Class, Race, and Poverty: Medical Technologies and Socia-Political 
Choices, 11 HARV. BLACKLETTER LJ. 115, 116-25 (1994); Vernellia R. Randall, Slaver. v, Segre-
gation and Racism: Trusting the Health Care System Ain't Always Easy! An African-American Per~ 
spective on Bioethics, 15 ST. LOUIS U. PUB. L. REv. 191, 195-204 (1996) [hereinafter Randall, 
Trusting the Health Care System]. 




21 Larry J. Pittman, Physician-Assisted Suicide in the Dark Ward: The Intersection of the Thir-
teenth Amer~dment and Health Care Treatments Having Disproportionate Impacts on Disfavored 
Groups, 28 SETON HALL L. REv. 774,808-11 (1998) (citing commentators on both sides of 
this issne) . 
22Id. at 811-12. 
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In addition, during the pre-Civil War period, Mrican Americans 
were used in various non-consensual medical experiments.23 Euro-
pean-American doctors often used living Mrican Americans in a wide 
variety of experimental contexts.24 During the 1800s, Europe an-
American physicians used Mrican Americans to develop gynecological 
surgical techniques,25 and to determine whether ether was an effec-
tive general anesthesia.26 Thomas Jefferson inoculated 200 of his 
slaves with the smallpox virus in order to determine the viability of his 
experimental vaccine.27 Other known medical experiments conducted 
on slaves included pouring boiling water on their spinal columns to 
discover whether this was an effective treatment for typhoid pneumo-
nia, and placing Mrican Americans in an open pit oven to determine 
if certain medications enabled them to withstand excessive tempera-
tures. 28 
European-American doctors, hospitals and medical schools also 
relied on the bodies of Mrican Americans for cadaver research and 
for training medical students.29 Medical institutions often sent people 
to steal recently buried bodies from African-American cemeteries in 
order to maintain a supply of cadavers.30 Additionally, Mrican-
American Siamese twins and other "freaks of nature" were displayed 
at medical conventions to entertain doctors and give them something 
at which to gawk.31 
Following the conclusion of the Civil War and emancipation, M-
rican Americans continued to confront overt racism in the health care 
sector.32 During Reconstruction, European-American doctors from 
23 Bernier, supra note 16, at 118-20; Pittman, supra note 21, at 812-13. 
24 Bernier, supra note 16, at 118-20; Pittman, supra note 21, at 812-13. 
25 See Bernier, supra note 16, at 118-19; Pittman, supra note 21, at 813. For example, 
Dr. J. Marion Sims, hailed as the founder of modern gynecology, repeatedly performed 
operations on a group of female slaves in order to develop a surgical procedure to cure 
vesico-vaginal fistula. See id. Some historical accounts indicate that Dr. Sims failed to pro-
vide the African-American women he experimented on with anesthesia, despite its avail-
ability. See id. Other accounts explain that Dr. Sims administered opium post-operatively to 
sedate and pacify the victims of his experiments. See Randall, Trusting the Health Care System, 
supra note 16, at 197. As a consequence, the women used in these experiments became 
addicted to narcotics. See id. 
26 Randall, Trusting the Health Care System, supra note 16, at 196. 
27Id. 
28Id. at 196-97. 
29 Pittman, supra note 21, at 812. 
30 Id. 
3! Randall, Trusting the Health Care System, supra note 16, at 196. 
32 Pittman, supra note 21, at 814-15. 
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both the North and the South discriminated against African Ameri-
cans.33 In response, the Freedmen's Bureau medical department es-
tablished ninety hospitals for African Americans throughout the 
South.34 Unfortunately, these hospitals were short lived.35 By 1868, 
only one of these health care facilities remained in operation.36 
B. Jim Crow Era 
During the decades of segregation, overt racism continued to 
prevail in America's health care system.37 In 1896, the Supreme Court 
delivered the now overruled Plessy v. Ferguson decision, holding that 
the segregation of African Americans and European Americans was 
not a violation of the Fourteenth Amendment's Equal Protection 
Clause of the United States Constitution.38 Similar to other segments 
of society, the health care establishment embraced the Plessy decision 
and the Jim Crow legislation that followed on the heels of the opin-
ion.39 As a consequence of the initial triumph of the separate but 
equal doctrine, African Americans were excluded from medical 
schools.40 This severely limited the number of African-American doc-
tors.41 Those African Americans who were already doctors were not 
permitted to practice medicine in hospitals run by European Ameri-
cans.42 Southern hospitals excluded African Americans from their 
premises completely, while hospitals in the North tended to operate 
separate wards for African American and European American pa-
tients.43 In response, African Americans worked to establish their own 
hospitals, medical schools and health care facilities.44 
During the Jim Crow era, African Americans continued to be un-
knowingly used in medical experiments as well.45 The most famous 
illustration of experimentation on African Americans during this era 
~3 [d. 
54 SMITH, supra note 16, at 12. 
55 [d. 
S6 [d. 
~7 See id. at 12-24; Bernier, supra note 16, at 121-22; Pittman, supra note 21, at 815. 
58 SMITH, supra note 16, at 14; see, e.g., Plessyv. Ferguson, 163 U.S. 537, 550-51 (1896). 
39 SMITH, supra note 16, at 14. 
40 See id. 
41 See id. 
42 [d. 
45 [d. at 14-21. 
44 SMITH, supra note 16, at 16-17. 
45 [d. at 24-27; Bernier, supra note 16, at 122-25. 
40 Boston College Third World Law journal [Vol. 21:35 
is the Tuskeegee Syphilis Study.46 Beginning in July 1932, the United 
States Public Health Services enrolled approximately 400 Mrican 
American men with syphilis and 200 African American men without 
syphilis in an experiment designed to determine the impact of un-
treated syphilis on the male body.47 These African Americans, most of 
whom were poor and uneducated, were not made aware that they had 
contracted syphilis.48 Rather, those who were part of the experiment 
were told that they had "bad blood. "49 In order to ensure that these 
men would remain part of the study, they were given burial insurance, 
hot meals and transportation to and from the hospital. 50 Even after 
the medical establishment became aware that penicillin was an effec-
tive treatment for syphilis, antibiotics were still withheld from the sub- . 
jects of this experiment.51 It was not until 1972, forty years after this 
experiment commenced, that the survivors of the Tuskeegee Syphilis 
Study were informed that they had syphilis and had been the subjects 
of the longest medical experiment in withholding treatment from 
humans in recorded history.52 
Explicit segregation in the realm of health care remained com-
pletely intact until the mid-1960s.53 In 1964, Congress passed the Civil 
Rights Act, which prohibited federally funded programs and institu~ 
tions from discriminating on the basis of race.54 The following year, 
Congress created the Medicare Program, which made almost all hos-
pitals the recipients of federal funding. 55 As a consequence of their 
participation in the Medicare Program, almost every hospital in the 
United States was forced to abide by the provisions of the Civil Rights 
Act of 1964.56 Despite attempts to prevent racial integration, medical 
facilities eventually came to treat patients and hire doctors of all 
races.57 
46 Bernier, supra note 16, at 122-23; Pittman, supra note 21, at 816. 
47 Bernier, supra note 16, at 122-23. 
48 Id. at 123. 
49 Pittman, supra note 21, at 816. 
50 Bernier, supra note 16, at 123. 
51Id. 
52 SMITH, supra note 16, at 25. 
53 Patricia A. King & Leslie E. Wolf, Empowering and Protecting Patients: Lessons for Physi-




57 See id. 
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C. Modern Day Racial Inequalities in Health Care 
Despite the gains that have been made since the passage of the 
Civil Rights Act of 1964, the health care industry remains plagued by 
racial discrimination.58 It should be noted that, while telling, the in-
formation that follows does not illustrate the complete extent to 
which Mrican Americans are currently discriminated against by the 
American health care institution.59 Due to the inadequate mecha-
nisms for racial data collection within the health care industry, 
specifically a failure to report and distribute health care statistics by 
race, a lack of coordination between agencies responsible for main-
taining health care data, and inconsistent definitions of race, it is im-
possible to fully realize the extent of racial discrimination within the 
medical sector. 60 
1. Mrican-American Health Status 
Statistical data indicates that Mrican-American babies have lower 
birth weights and are more likely to die during the first year of life 
58 See generally Council on Ethical and Judicial Mfairs, Black-lWlite Dispmities in Health 
CaTe, 263 JAMA 2344 (1990); Barbara A. Noah, Racist Health Care?, 48 FLA. L. REv. 357 
(1996) [hereinafter Noah, Racist Health Care?] ;Jane Perkins, Race Discrimination in America s 
Health Care System, 27 CLEARINGHOUSE REv. 371 (1993). The form of racism that currently 
exists in the health care sector of American society is sometimes described as institutional-
ized racism. Vernellia R Randall, Racist Health Care: Reforming an Unjust Health Care System 
to Meet the Needs of African Americans, 3 HEALTH MATRIX 127, 144 (1993) [hereinafter Ran-
dall, Reforming an Unjttst Heath Care System]. Racism comes in different forms. Id. Within 
the context of this Note it is important to draw a distinction between individual racism and 
institutionalized racism. See id. Individual racism is overt and typically occurs when indi-
viduals of one race act against individuals of another race. Id. In contrast, institutionalized 
racism is covert and typically occurs when an entire racial community acts against another 
racial community. Id. Institutional racism is 
more subtle, less identifiable in terms of specific individuals committing the 
acts. But it is no less destructive of human life .... When black babies die 
each year because of lack of proper food, shelter and medical facilities, and 
thousands more are destroyed and maimed physically, emotionally, and intel-
lectually be.cause of the conditions of poverty and discrimination in the black 
community, that is a function of institutional racism. 
STOKELY CARMICHAEL & CHARLES E. HAMILTON, BLACK POWER: THE POLITICS OF LIBERA-
TION IN AMERICA 4 (1967). 
59 See Perkins, supra note 58, at 377. 
60 Id. at 377-79. 
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than children born to European-American parents.61 For example, 
Mrican-American babies are twice as likely to die during the first year 
of life as European-American babies, and children born in countries 
that are significantly less developed than the United States, such as 
Kuwait, Costa Rica and Singapore, are more likely to live past age one 
than children born to Mrican Americans in the United States.62 
In addition to the dismal data pertaining to differences in infant 
mortality and low birth weight, Mrican Americans are generally more 
likely to die prematurely than European Americans.63 The life expec-
tancy for Mrican-American males is seven years lower than the life 
expectancy for European-American males.64 Similarly, the life expec-
tancy for Mrican-American females is five years lower than the life ex-
pectancy for European-American females.65 Skeptics of this statistical 
measurement are quick to point out that the homicide rate for Mri-
can Americans is higher than the homicide rate for European Ameri-
cans.66 When statistical data is examined in various cause of death 
categories, however, it becomes readily apparent that the higher pre-
mature death rate for Mrican Americans is not simply a ramification 
of a higher incidence of homicide within Mrican-American communi-
ties.67 For example, Mrican-American men have 100% more deaths 
due to diabetes, 92.6% more deaths due to cerebral vascular disor-
ders, 88.4% more deaths from cirrhosis of the liver and 8l.8% more 
deaths due to pulmonary infectious diseases than European-American 
males.68 Additionally, African Americans are more likely than Euro-
pean Americans to contract and suffer from certain diseases such as 
tuberculosis, asthma, heart disease, cervical cancer, acute respiratory 
disease, appendicitis, hernia, pneumonia, influenza, and hyperten-
61 Id. at 372. Low birth weight babies, any infant weighing less than 2500 granIs, are 
more likely to have moderate and severe forms of mental retardation, cerebral palsy, sei-
zure disorders, blindness, hearing loss and behavioral, learning and language disorders. Id. 
Thus, babies with low birth weights are more likely to be sickly throughout life than babies 
born with normal birth weights. Id. Studies indicate that African-American babies are 
222.81 % more likely to suffer from low birth weight than European-American babies. 
Randall, Reforming an Unjust Health Care System, supm note 58, at 140. 




66 See id. at 372; Randall, Reforming an Unjust Health Care System, supra note 58, at 142. 
67 See Randall, Reforming an Unjust Health Care System, supra note 58, at 142. 
68 Id. 
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sion.69 In summary, when statistical information such as birth weight, 
infant mortality, life expectancy and the likelihood of contracting cer-
tain diseases is examined, it becomes readily apparent that the status 
of Mrican-American health is lower than the status of European-
American health.70 
2. Mrican-American Access to Treatment 
Despite a tremendous need for medical treatment, many Mrican 
Americans cannot effectively access medical care.7I This inaccessibility 
is due to a variety of factors, including a lack of health insurance, an 
inadequate number of health care facilities, "patient dumping," 
difficulty in obtaining prescription drugs and an insufficient number 
of Mrican-American doctors. 72 
Portions of the Mrican-American community are unable to access 
medical treatment because they do not have medical insurance.73 
United States citizens do not have a right to health care.74 An individ-
ual's ability to obtain medical care depends on their ability to obtain 
employment that provides medical insurance, or on their ability to 
pay for health care directly.75 Thus, access to medical care is depend-
ent upon income level and employment in a position that provides 
insurance.76 The United States' Mrican-Anlerican population is dis-
proportionately poor.77 Mrican Americans do not tend to hold em-
ployment positions that provide medical benefits.78 Additionally, 
Medicaid, public medical insurance for the poor, has financial eligibil-
69 Perkins, supra note 58, at 372. 
70 See Council on Ethical and Judicial Mfairs, supra note 58, at 2344-46; Perkins, supra 
note 58, at 372-77. 
71 Perkins, supra note 58, at 373-77. 
72 See CLOVIS E. SEMMES, RACISM, HEALTH AND POST INDUSTRIALISM: A THEORY OF 
AFRICAN-AMERICAN HEALTH 112 (1996); Perkins, supra note 58, at 373-77. 
73 See Perkins, supra note 58, at 373-74. 
74 [d. at 373. 
75 [d. 
76 See id. 
77 [d. at 374. One third of Mrican Americans are below the poverty line. [d. In contrast, 
lO% of European Americans are below the poverty line. [d. Additionally, 30% of Mrican-
American households report no assets and 50% of Mrican-American families report assets 
less than $5,000. [d. 
78 Perkins, supra note 58, at 374. Twenty-four percent of Mrican Americans are without 
medical insurance. [d. Only 38.1 % of Mrican-American children are covered by employ-
ment provided medical insurance. [d. Close to 14% of European Americans are without 
medical insurance. [d. 
44 Boston College Third World Law journal [Vol. 21:35 
ity requirements that strictly limit the number of needy individuals 
who qualify.79 Thus, many Mrican Americans are without any form of 
medical insurance.8o 
Individuals that do not have the ability to pay for health care, 
employer-provided medical insurance, or Medicare are- less likely to 
have regular, preventative care from the medical profession.81 Statis-
tics indicate that those without medical insurance are much less likely 
to have yearly physical exams, pap smears, blood pressure checks, and 
breast exams.82 Furthermore, uninsured patients are more likely to 
utilize hospital emergency rooms as their primary source of health 
care.83 
Moreover, hospitals use facially neutral practices to effectively 
limit Mrican-American access to their facilities.84 For example, private 
hospitals and physicians frequently exclude or severely limit the num-
ber of low-income patients treated.85 Since a large percentage of Afri-
can Americans are poor, their access to medical care at private facili-
ties is limited.86 This problem is seriously exacerbated by the fact that 
public hospitals located in African-American communities are increas-
ingly closing, relocating to areas with a high European-American 
population, becoming private facilities or limiting the size of their 
emergency rooms.87 Thus, larger numbers of African Americans are 
forced to rely on a dwindling number of health care resources.88 
Hospitals in the United States also have long maintained the 
practice of transferring patients considered "undesirable" for a variety 
of reasons to other health care facilities.89 This practice has come to 
79 See id. 
80 Seeid. at 373-75. 
81 Id. at 374. 
82Id. 
83 Perkins, supra note 58, at 374. 
84 Randall, Trusting the Health Care System, supra note 16, at 210-11. 
85 Marianne L. Engelman Lado, Breaking the Barriers of Access to Health Care: A Discussion 
of the Rnle of Civil Rights Litigation and the Relationship Between Burdens of Proof and the Expen-
enceofDenia~ 60 BROOK. L. REv. 239, 245-46 (1994). 
86 Id. 
87 Id. at 248-49; Randall, Trusting the Health Care System, supra note 16, at 210-11. 
88 See Lado, supra note 85, at 243-52; Randall, Trusting the Health Care System, supra note 
16, at 210-12. 
89 Randall, Trusting the Health Care System, supra note 16, at 211. 
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be known as "patient dumping. "90 Private hospitals have historically 
transferred (dumped) Mrican Americans to public hospitals.91 
In 1986, Congress enacted the Emergency Medical Treatment 
and Active Labor Act (EMTAlA) as part of the Omnibus Reconcilia-
tion Act (COBRA) .92 This legislation, passed with the intention of 
curbing patient dumping, made the once commonplace practice ille-
ga1.93 But, despite good intentions on Capitol Hill, EMTAlA has not 
entirely rectified the problem of patient dumping.94 A lack of legisla-
tive enforcement mechanisms, coupled with loopholes in the Act, 
work to ensure that the phenomenon of patient dumping remains a 
barrier for African Americans who attempt to access medical care.95 
Scholars devoted to the study of racial discrimination in the 
medical profession have also drawn attention to the fact that Mrican 
Americans are less likely to be prescribed medication than European 
Americans.96 For example, in 1994 the New England Journal of Medi-
cine reported that Mrican-American AIDS patients received prescrip-
tions for needed medications less frequently than European-American 
AIDS patients even after income, insurance status, mode of HIV 
transmission and place of residence were controlled for. 97 Another 
study conducted on racial discrimination in the dissemination of pre-
scription medication found that Mrican-American children were less 
likely to leave doctor's appointments with prescriptions than Euro-
pean-American children.98 
Mrican Americans also comprise a disproportionately small per-
centage of practicing doctors in the United States.99 Despite the fact 
that Mrican Americans account for 12% of the population, only 3% 
90 ld. 
9l See id. 
92WILLIAMJ. CURRAN ETAL., HEALTH CARE LAw AND ETHICS 142 (1998). 
93 Seeid. 
94 Randall, Trusting the Health Care System, supra note 16, at 211-12. 
951d. 
96 Barbara A. Noah, Racial Disparities in the Delivery of Health Care, 35 SAN DIEGO L. REv. 
135,147-50 (1998) [hereinafter Noah, RaciaIDisparities]. 
97 ld. at 148. 
98 ld. at 148-49. After controlling for variables such as the age of the child, the educa-
tion level of the child's mother, health insurance coverage and poverty status, this study 
revealed that of all children that made at least one visit to the doctor, African-American 
children were one half as likely as European-American children to be prescribed a pre-
scription medication. ld. 
99 SEMMES, supra note 72, at 112. 
46 Boston College Third World Law Journal [Vol. 21:35 
of American doctors are African American.100 Increasing the number 
of Mrican-American doctors through improved education and medi-
cal school admission policies that take race into account will increase 
Mrican-American access to health care because Mrican-American 
doctors tend to specialize in primary care.101 Furthermore, Mrican-
American doctors generally practice in locations accessible to Mrican-
American communities.102 
3. Treatment Received 
Research also reveals that, on average, Mrican Americans receive 
less aggressive treatment for various physical ailments even after in-
come adjustments are made to the data.103 For instance, studies per-
taining to cardiac treatment reveal that Mrican-American men are 
half as likely to undergo coronary angiography and one third as likely 
to undergo coronary artery bypass surgery as European-American 
men.104 These astonishing statistics are even more troubling in light of 
the fact that African-American males are more likely to suffer from 
heart disease than European-American males.l°5 
Studies also indicate that the intensity of treatment within the 
realm of internal medicine is influenced by racial considerations.l°6 
Even after income differentials are taken into account, research re-
veals that Mrican-American patients are less likely to be treated ag-
gressively for illnesses and/or conditions such as pneumonia, kidney 
failure, and glaucoma than European Americans.107 The Journal of 
the American Medical Association also reports that African-American 
women have fewer cesarean sections than European-American women 
even when researchers account for the degree of clinical difficulty of 
100 [d. 
101 See id. 
102 [d. 
103 See Council on Ethical and Judicial Affairs, supra note 58, at 2344-46. 
104 [d. at 2344. 
105 See id. 
106 See Perkins, supra note 58, at 376. 
107 [d. African-American individuals suffering from glaucoma are less likely to undergo 
corrective surgery than European Americans. [d. The magnitude of the disparity differs 
with geographic location. [d. In the mid-Atlantic region, African Americans are 29% less 
likely to undergo surgery for glaucoma than European Americans. [d. In the South, Afri-
can Americans are 50% less likely than European Americans to have an operation to treat 
their glaucoma. [d. 
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the childbirth(s).lo8 Within the mental health sector of health care, 
treatment disparities based on race also exist,l09 For example, Mrican 
Americans are less frequently considered viable patients for psycho-
therapy, are more likely to be cared for by an inexperienced therapist 
and are treated for shorter periods of time, and less intensively, than 
European-American mental health patients.110 
Research indicates that, after adjusting for income, some proce-
dures are in fact performed with greater frequency on Mrican-
American patients than on European Americans suffering from the 
same ailments.1ll Unfortunately, those procedures are of the type that 
most people, regardless of race, would hope to avoid undergoing. ll2 
For example, Mrican Americans are three times more likely than 
European Americans to have a partial or total amputation of the 
leg. ll3 Similarly, Mrican-American men are twice as likely to have a 
bilateral orchietomy in attempts to treat prostate cancer than Euro-
pean-American men.1l4 The implications of this research indicate that 
the medical profession may detect certain illnesses in Mrican Ameri-
cans at more advanced stages.1l5 As a consequence, less invasive and 
less drastic treatment measures are no longer viable.1l6 
4. Experimentation/Clinical Research 
Even though present day evidence of medical experimentation 
on non-consenting Mrican Americans is presently unavailable, it is 
important to recognize that during the latter portion of the twentieth 
century Mrican Americans continued to be unknowingly used as sub-
jects in medical experiments.1l7 In 1963, the United States Public 
Health Service and the American Cancer Society provided funding 
for a research project conducted by doctors working at the Jewish 
Chronic Disease Hospital of Brooklyn, New York. ll8 This research ex-
108 Council on Ethical and Judicial Affairs, supra note 58, at 2345. 
109 See Perkins, supra note 58, at 376. 
110Id. 
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m See Bernier, supra note 16, at 122. 
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periment injected live cancer cells into uninformed, non-consenting 
African-American patients.119 
The year 1972 was witness to yet another disturbing incidence of 
medical experimentation on African Americans.12o In this instance, 
twenty women, most of whom were African-American, were bused 
from Chicago, Illinois to Philadelphia, Pennsylvania in order to un-
dergo abortions with a new medical device known as the Super 
Coil.121 Despite the prevailing sentiment of the medical community 
that the Super Coil should not be used to perform abortions, this de-
vice was used on these African-American women.122 As a consequence, 
many of the women suffered uncontrollable bleeding which resulted 
in shock and necessitated complete hysterectomies in order to save 
their lives.123 
Other research pertaining to racism in medical research reveals 
that in recent years African-American subjects have been entirely ex-
cluded from studies undertaken on new drugs.124 This exclusion is 
said to be motivated by a desire to streamline research and eliminate 
unnecessary variables.125 As a consequence of this failure to include 
representatives from minority populations in clinical trials, the re-
search community has potentially put members of minority popula-
tions at risk by placing drugs in the market without understanding 
how entire segments of the populous will react to them.126 In an at-
tempt to ameliorate this situation, the National Institute of Health 
issued rules in 1990 requiring pharmaceutical trials to be conducted 
on minorities unless there is a clear and compelling reason for the 
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II. KIDNEY TRANSPLANTATION: BACKGROUND INFORMATION AND 
EXPLANATION OF FEDERAL REGULATION 
A. The Kidney, Kidney Disease and Treatment Options 
49 
The kidney is a bean-shaped organ that, on average, weighs 140 
grams,128 Humans have two kidneys located behind the lower ab-
dominal cavity,129 The human kidneys filter out various substances 
from an individual's blood,l3° Each day roughly 180 liters of fluid are 
passed through the kidneys.l3l Some of what is filtered out is reab-
sorbed by the kidneys in order to maintain a proper balance of elec-
trolytes and fluids.132 The majority of substances filtered from the 
blood are turned into urine by the kidneys.I33 Thus, the kidneys work 
to ensure that human beings are not poisoned by the accumulation of 
metabolism's waste products,134 Kidney failure has many potential 
causes including injury, infection, kidney stones, cancer and disorders 
in other parts of the human body, such as high blood pressure or dia-
betes.I35 At times kidney failure occurs without any apparent cause,136 
When an individual's kidneys fail to function properly waste products 
build up in their body, resulting in sickness or death.I37 
There are two main treatment options for chronic kidney failure: 
hemodialysis and kidney transplantation,138 Hemodialysis is a means 
by which waste products are filtered from the blood by a machine 
that, in effect, performs the function of the kidneys,139 On average, 
patients receiving dialysis treatment for chronic kidney failure must 
undergo treatment three times a week. I40 Hemodialysis sessions tend 
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to last between four to six hours and typically take place at either a 
hospital or a dialysis center.141 
Hemodialysis is far from a pleasant experience.142 Dialysis pa-
tients are often plagued by fatigue; some patients are so tired that 
they become unable to work or live a normallifestyle.143 Additionally, 
it is not uncommon for individuals undergoing hemodialysis to re-
quire surgery to repair the blood vessels used in dialysis treatment.144 
Individuals undergoing dialysis may also be susceptible to infection 
because of problems with sterility.145 However, the problem of sterility 
has been somewhat mitigated because now most dialysis machines 
have disposable parts.146 
The second treatment option available to individuals suffering 
from chronic renal failure is kidney transplantation.147 Although the 
notion of organ transplantation is ancient, the first successful kidney 
transplantation was not performed until 1954.148 The kidney is a rela-
tively easy organ to transplant because it does not need to be con-
nected with the central nervous system in order to function prop-
erly.149 When transplanting a kidney, the surgeon only needs to 
connect the organ to a major artery, a m~or vein and the ureter, a 
tube-like structure that connects the kidney to the bladder.15o 
141Id. 
142 See Kevin McCoy, Wait for Organs is Long and Painful: Black New Yorkers in Need of Kid-
neys Suffer Longest, N.Y. DAILY NEWS, Aug. 9, 1999, at 6. 
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With surgical technique near perfection in the area of renal 
transplantation, one of the stumbling blocks to kidney transplantation 
is rejection by the immune system.I51 In order to prevent the recipi-
ent's immune system from attacking the transplanted organ, drugs 
which suppress the immune system are administered to the recipi-
ent. I52 A side effect of these medications is a weakened immune sys-
tem, which creates an inability to fight disease. I53 
Another m.yor obstacle in the area of kidney transplantation is 
the lack of available organs.I54 Transplantable kidneys may be ob-
tained from either living or cadaver donors.I55 Since human beings 
have two kidneys and are able to live a normal life with only one, the 
medical establishment permits living relatives to donate one of their 
kidneys to a family member.I56 Kidneys can also be obtained from de-
ceased individuals who indicate that they are willing to donate their 
organs upon their death.I57 
Despite efforts to increase organ donation, the public response 
has been dismal. I58 Many refuse to donate their organs upon death 
because they fear doctors will hasten their death when it becomes 
known that they are an organ donor, because they are unwilling to 
face their own mortality or because they have religious convictions 
that require that the body of a deceased person be kept intact.I59 The 
failure of individuals to donate their organs, while significant, is not 
the only reason why the United States faces a shortage of transplant-
able organs.I60 Often, the organs of individuals who have indicated 
that they wish to be an organ donor upon their death are not har-
vested. I61 Before doctors harvest the organs of an individual who indi-
cated a desire to donate while still alive, consent is almost always 
sought from surviving family members.I62 It is not uncommon for 
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family members to withhold consent, or for physicians to neglect to 
ask for permission to harvest the organs of a deceased individual.163 
Typically, patients suffering from chronic renal failure prefer kidney 
transplantation to dialysis. l64 Studies indicate that individuals that 
have undergone successful renal transplants enjoy a higher quality 
and longer life than patients maintained on dialysis.165 
B. Regulation of Organ Allocation 
The allocation of organs is governed by the National Organ 
Transplant Act of 1984,166 This federal legislation created the Organ 
Procurement and Transportation Network (OPTN), a private, non-
profit organization, to develop standards for the allocation of trans- . 
plan table organs and to create a system to match individuals donating 
organs with medical patients in need of a replacement organ.167 Since 
1986, the Federal Department of Health and Human Services has 
awarded the contracts to operate OPTN to the United Network for 
Organ Sharing (UNOS),168 UNOS is an organization comprised of 
organ procurement agencies, transplant surgery centers, medical 
laboratories, volunteers and advocacy groups, organ donors and their 
families, organ recipients and their families, and patients awaiting an 
organ for transplantation.169 
The individual organ procurement agencies, one sector of 
UNOS' membership, are charged with the duty of obtaining organs 
from the geographical area where they are located.170 Organ pro-
curement agencies also allocate organs to individuals in need of an 
organ who reside in the same geographical location as the organ pro-
curement agency.l7l If no one residing in the same geographic area is 
in need of the procured organ, then the organ may be given to an-
other organ procurement agency.172 As a result of the fact that UNOS 
most all doctors are unwilling to remove organs from a deceased individual unless consent 
is obtained first from surviving family members. CURRAN ET AL., supra note 92, at 721. 
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maintains several waiting lists based on geographical location, an in-
dividual's place of residence can potentially impact their ability to ob-
tain a much needed organ for transplantation.173 
As a whole, UNOS issues allocation guidelines which the individ-
ual organ procurement agencies abide by when allocating organs to 
individuals on UNOS' waiting lists. I74 Generally speaking, UNOS allo-
cation guidelines give consideration to the amount of time an indi-
vidual has spent on an UNOS waiting list, medical urgency and possi-
bility for successful transplantation.175 Specific UNOS allocation 
guidelines for kidneys do not place a significant amount of emphasis 
on medical urgency because most patients seeking a kidney for trans-
plantation can be maintained on dialysis. I76 Rather, emphasis is placed 
on the length of time the kidney recipient will benefit from the trans-
plant and the compatibility of the donor and the recipient)77 At this 
time, UNOS has not issued guidelines to help organ procurement 
agencies determine who should be placed on UNOS waiting lists.178 
Thus, local organ procurement agencies have been free to develop 
their own policies concerning which individuals should be placed on 
organ allocation waiting listsP9 
III. EMPIRICAL EVIDENCE PERTAINING TO RACIAL DISCRIMINATION IN 
KIDNEY TRANSPLANTATION 
A. African-American Access to Transplantable Kidneys: Increased Need and 
Decreased Likelihood of Receipt 
Studies indicate that African Americans are more likely than 
European Americans to have chronic renal failure, and thus more 
likely to be in need of a kidney transplant. ISO Data reveals that even 
though African Americans comprise only 12% of the population of 
the United States, they comprise 34% of the people suffering from 
173 CURRAN ET AL., supra note 92, at 767, 774-75. Waiting list times vary considerably 
with geographic location. Id. 
174Id. at 767. 
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chronic renal failure in the United States.18l Experts think that the 
African-American population's high rate of renal failure is due to a 
form of high blood pressure known as low-renin hypertension.182 Sci-
entists suspect that low-renin hypertension is more prevalent among 
African Americans because the kidneys of Mrican Americans evolved 
under the pressure of limited access to salt.183 In response to inade-
quate amounts of salt, experts believe that African Americans devel-
oped cellular mechanisms that permitted them to increase their salt 
retention.lM In contrast, African-American salt intake in the modern 
era is high.lss Consequently, excess salt in the diets of African Ameri-
cans coupled with a genetic propensity to retain salt has increased the 
likelihood that Mrican Americans will suffer from low-renin hyperten-
sion and thus chronic renal failure. l86 Additionally, due to a lack of 
access to adequate health care,187 African Americans are less likely 
than European Americans to be diagnosed with high blood pressure 
or to receive treatment for high blood pressure prior to developing 
serious renal damage.188 
Despite having greater need for replacement kidneys than Euro-
pean Americans, African Americans are less likely to receive a kidney 
transplant than Europeans Americans or other minorities.189 A study 
reported in the Journal of the American Medical Association revealed 
that patients treated at medical facilities which primarily serve Euro-
pean-American communities and are located in high income areas 
are more than twice as likely to be the recipient of a kidney donation 
as are patients treated by hospitals that typically serve African-
American patients and are located in low income areas.190 Discrepan-
cies based on race continue to exist after controlling for variables 
such as the cause of kidney failure, age and income.19l Even though 
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European Americans account for only 61 % of the nation's dialysis 
population, they receive 74% of all kidney transplants.192 In contrast, 
Mrican Americans account for 33% of the nation's dialysis population 
and receive only 22% of the kidneys available for transplantation.193 
Studies show that, on average, European Americans have a 78% 
higher chance of obtaining a kidney transplant than Mrican Ameri-
cans, and that Mrican Americans spend twice as much time on organ 
donation waiting lists as European Americans.194 
B. -why African Americans Receive Fewer Kidneys 
Various possible explanations have been offered to explain why, 
despite a more acute need for kidneys, Mrican Americans are less 
likely than European Americans to be recipients of kidney donations. 
First, attention has been given to the fact that Mrican Americans are 
less likely to donate kidneys than European Americans.195 Data indi-
cates that, during 1998, Mrican Americans donated only 12% of all 
living transplants and only 8% of cadaveric kidneys.196 Based on a 
long, tortuous history of mistreatment and discrimination by the 
medical sector, Mrican Americans tend to distrust the health care es-
tablishment, resulting in a decreased desire to make living kidney do-
nations because they fear not receiving adequate medical treatment 
during the donation period.197 Also, some Mrican Americans are less 
likely to gift their organs upon death because they suspect that once 
they agree to become organ donors their lives will be valued less.198 
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Second, the possibility exists that doctors are less likely to place 
Mrican-American patients on UNOS waiting lists than European-
American patients.199 Before a patient can be placed on an UNOS 
waiting list, a doctor must evaluate the patient and determine whether 
the individual should be referred to an organ procurement agency, 
which will then decide whether to put the patient on the waiting 
list.2°O Historically, UNOS has not issued guidelines to help physicians 
determine who should be referred to procurement agencies for 
placement on waiting listS.201 The possibility exists that doctors make 
racial value judgments at this juncture.202 The potential for racially-
biased decision making exists at this stage, as much as at the organ 
allocation stage of the transplant process.203 
Third, until recently, UNOS guidelines for the allocation of kid-
neys required a close antigen match between the donor and the re-
cipient.204 As mentioned above, the guidelines issued by UNOS for 
the allocation of kidneys do not place much emphasis on medical ur-
gency because individuals with chronic renal failure can be main-
tained on dialysis.205 Rather, kidney allocation guidelines have tradi-
tionally focused on human leukocyte antigen (HLA) matching.206 
Thus, individuals on UNOS kidney waiting lists that exhibit a close 
HLA match to the donated organ are more likely to be chosen as the 
transplant recipient.207 Since the HLA match percentage between M-
rican Americans and European Americans is low, Mrican Americans, 
who, as a population, are in the greatest need of kidneys, do not 
benefit from the emphasis UNOS places on close HLA matching.208 
The National Organ Transplant Act of 1984 directed the Organ 
Procurement and Transportation Network, whose contract has been 
continuously awarded to UNOS, to allocate all organs "equitably 
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among transplant patients" and "in accordance with established 
medical criteria. "209 Based on this explicit legislative directive, it is 
clear that Congress intended for equitable and practical outcome con-
siderations to influence the allocation of organs.210 The emphasis 
placed on close antigen matching in the area of kidney distribution 
leads to the inescapable conclusion that UN OS has placed emphasis 
on an effective outcome at the expense of an equality-based out-
come.2l1 The small gains that close tissue matching contributes to the 
overall success of kidney transplantation are not a sufficient 
justification for disadvantaging African Americans in need of kidney 
transplants.212 In addition, it is important to point out that new anti-
rejection drugs, such as cyclosporine, have the potential to make close 
HLA matching medically unnecessary.213 The next portion of this 
Note will explore possible responses to the lack of racial parity in the 
allocation of transplantable kidneys. 
IV. LEGAL RESPONSES TO RACIAL DISPARITIES IN THE ALLOCATION OF 
KIDNEYS214 
A. Increase African-American Donation: Education, Publicity 
Campaigns, Establishment of Greater Trust in the Health Care System 
and ''Presumed Consent" Laws 
In order to increase the percentage of African Americans making 
either cadaver or living kidney donations, a multifaceted approach 
must be ·pursued.215 Via educationally oriented publicity campaigns, 
African-American communities should be made aware that members 
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of their race suffer a higher incidence of kidney failure than other 
racial groups in the United States and that, as a group, African 
Americans donate fewer organs than other racial sectors of American 
society.216 In addition to informing and educating African Americans 
about the shortage of transplantable kidneys and thus, the need for 
increased donation, efforts must be undertaken to foster African-
American trust in the United States health care system.217 The goal of 
instilling African-American trust in the medical establishment can be 
pursued by acknowledging past wrongs.218 Working to eliminate pres-
ent inequalities by bringing lawsuits that challenge discriminatory 
practices will also work to create African-American trust. 219 Increasing 
the number of African-American doctors and nurses has the potential 
to ameliorate the problem of African-American distrust in the health 
care industry as well.22o 
Suggestions have also been made that the general problem of an 
inadequate supply of transplantable organs can be rectified by passing 
legislation that mandates "presumed consent" to organ donation.221 
These proposed statutes would presume that all mentally competent 
Americans over the age of eighteen consent to the collection of 
transplantable organs upon their death.222 Proposals for presumed 
consent legislation typically contain opt-out provisions so that individ-
ual autonomy and self-determination, two strong tenets of American 
government, are not destroyed.223 Advocates of presumed consent 
statutes draw attention to the fact that several nations, such as Austria, 
Belgium, Israel and New Zealand, have enacted presumed consent 
laws.224 Finally, advocates point out that twenty US states have pre-
sumed consent laws for cornea and pituitary gland donation. 225 
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B. Development of UNOS Waiting List Criteria 
As discussed in Part III, physicians may be less likely to place Afri-
can Americans on UNOS kidney allocation waiting lists than Euro-
pean Americans.226 This is potentially a significant obstacle to Mrican 
Americans in need of a kidney transplantation because placement on 
an UN OS waiting list is an essential first step in order to receive con-
sideration for a kidney donation.227 In order to help eliminate racial 
discrimination at this juncture, UNOS is in the process of developing 
standard criteria for determining when an individual should be 
placed on kidney allocation waiting lists.228 As we have seen in regards 
to the guidelines that UNOS has prescribed for the actual allocation 
of kidneys to patients already on organ waiting lists, however, the cri-
teria themselves might actually contribute to disparities based on race 
and therefore fail to improve this dismal situation.229 Thus, while the 
creation of UNOS guidelines pertaining to the placement of patients 
on organ donation waiting lists can generally be perceived as a step 
towards greater equality in organ allocation, only time will tell 
whether in practice these guidelines will work to ameliorate racial dis-
crimination.23o 
C. UNOS Kidney Allocation Guidelines 
In 1995, UNOS responded to concerns pertaining to racial dis-
parities in kidney allocation by modifying kidney allocation guide-
lines.231 The amended UNOS guidelines still take antigen matching 
into consideration when making allocation determinations.232 Now, 
however, UNOS places less emphasis on partial antigen matches than 
it previously did, and gives greater consideration to time spent on the 
waiting list.233 As a result of these alterations in the UNOS kidney allo-
cation guidelines, a larger percentage of kidneys are being donated to 
African-Americans witlwut the anticipated decline in kidney transplant 
226 SeeDooley & Gaston, supra note 144, at 715-16. 
227 See id. 
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survival rate.234 In fact, since the kidney allocation changes were made 
in 1995, the survival rate for kidney transplant patients has actually 
improved.235 
While these changes should be applauded, it is important to rec-
ognize that more drastic alterations need to be made before racial 
parity in the area of kidney allocation will exist.236 Based on the rela-
tive success of the 1995 changes to the UNOS kidney allocation guide-
lines, attention should be given to the possibility of placing even less 
emphasis on antigen matching.237 
D. Litigation 
1. Potential Claims Under the Equal Protection Clause ofthe 
Fourteenth Amendment to the United States Constitution 
The suggestion has been made that a claim against UNOS could 
be brought under the Equal Protection Clause of the Fourteenth 
Amendment to the United States Constitution.238 While this means of 
pursuing greater racial equality in kidney allocation is within the 
realm of possibility, obstacles stand in the way of the potential success 
of an Equal Protection claim against UNOS.239 For an Equal Protec-
tion challenge to be effective, the plaintiff has to overcome two major 
hurdles: state action and intent to discriminate.240 
To determine whether or not state action is present in the Equal 
Protection context, the Supreme Court considers whether the defen-
dant is engaged in a public function, or whether a sufficiently close 
nexus exists between the defendant and the government or, finally, 
whether the government compels the harm caused by the defen-
dant.241 One scholar has made the argument that UNOS qualifies as a 
state actor, under the government compulsion test, due to the gov-
234 See CURRAN ET AL., supra note 92, at 783; Dooley & Gaston, supra note 144, at 720. 
235 Dooley & Gaston, supra note 144, at 720. 
236 See id. 
237 See id.; Noah, Racial Disparities, supra note 96, at 145-46. 
238 See Benjamin Mintz, Analyzing the OPTN Under the State Action Doctrine-Can UNOS's 
Allocation Criteria Survive Strict Scrutiny?, 28 COLUM. J.L. & Soc. PROBS. 339, 384-96 (1995). 
239 See id. at 367-76 (discussing whether UNOS is a state actor). 
240 Id. at 367-76, 384. 
241 Id. at 358-59. 
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ernment's involvement in the making of UNOS rules and guide-
lines.242 
The plaintiff would also need to show that UNOS intended to 
discriminate against Mrican Americans.243 In Washington v. Davis, the 
Supreme Court made clear that there must be intentional, purposeful 
discrimination in order to state a claim under the Equal Protection 
Clause; discriminatory impact alone is not enough to establish a 
prima facie Fourteenth Amendment Equal Protection claim.244 Since 
there is seemingly no evidence of purposeful discrimination on the 
part of UNOS, this is a significant obstacle.245 An argument has been 
made, however, that a potential plaintiff bringing a suit against UNOS 
could claim that, although UNOS kidney allocation guidelines are not 
facially discriminatory, the emphasis placed on antigen matching is, in 
effect, the equivalent of an explicit racial classification and thus, the 
Supreme Court is required to evaluate UNOS kidney allocation guide-
lines under the rubric of strict scrutiny.246 Because a potential plaintiff 
challenging UNOS under the Equal Protection Clause would need to 
overcome the significant obstacles of state action and intent to dis-
criminate, an Equal Protection claim may not be the best legal option 
for Mrican-American plaintiffs.247 
2. Potential Claims Under Tide VI of the Civil Rights Act of 1964 
Title VI of the Civil Rights Act of 1964 is better suited to the goal 
of bringing about increased racial equality in the allocation of trans-
plantable kidneys.248 Title VI of the Civil Rights Act of 1964 requires 
programs receiving federal funding to treat individuals of different 
races, colors and national origins equally.249 It reads: "No person in 
the United States shall, on the grounds of race, color, or national ori-
gin, be excluded from participation in, be denied the benefits of, or 
be subjected to discrimination under any program or activity receiv-
242 Id. at 374-76. 
243 See Mintz, supra note 238, at 384. 
244 Washington v. Davis, 426 U.S. 229, 239 (1976). 
245 See Mintz, supra note 238, at 384. 
246 See id. at 386-89. 
247 See id. at 367-76, 384. 
248 See Amy Jurevic, Disparate Impact Under Title VI: DiSC1imination, By Any Other Name, 
Will Still Have the Same Impact, 15 ST. LOUIS U. PUB. L. REv. 237, 242-49 (1996). 
249 See 42 U.S.C. § 2000d (1994). 
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ing Federal financial assistance. "250 Under Title VI, those seeking fed-
eral funding have a choice to make: they can either accept federal 
financial assistance and consequently accept the conditions attached 
to the receipt of those funds, equal treatment of all races, or they can 
forego federal funding and be free of the legal obligation to treat 
races equally.251 As a consequence of Medicare/Medicaid legislation, 
almost all hospitals in operation in the United States receive federal 
funding and thus have a Title VI obligation not to discriminate on the 
basis of race, color or national origin.252 Because Title VI is vague, 
administrative regulations have been required for interpretation and 
enforcement of this statute.253 
Title VI has two possible enforcement mechanisms.254 First, Title 
VI provides for administrative enforcement via the Department of 
Health and Human Services' (HHS) Office of Civil Rights (OCR).255 
In practice, unfortunately, OCR does not serve as an effective en-
forcement mechanism for Title VI because OCR has failed to collect 
the data necessary to determine whether hospitals and other health 
care facilities are in compliance with Title VI.256 Without such data, it 
is difficult for OCR to ascertain the existence of racial discrimination 
and thus to sanction hospitals in violation of Title VI.257 In order to 
bring about greater racial equality in the allocation of organs for 
transplantation, a suit could be brought against HHS claiming that 
the agency's failure to monitor, and consequently sanction, caused 
injury-in-fact to the plaintiff.258 In order to present a justiciable claim 
against HHS, the plaintiff would also need to demonstrate that a judi-
cial remedy is available.259 
250 Id. 
251 Id.;Jurevic, supra note 248, at 240. 
252 See Perkins, supra note 58, at 379. 
253 Daniel K. Hampton, Title VI Challenges fry Private Parties to the Location of Health Care 
Facilities: Toward aJust and EjJective Action, 37 B.C. L. REv. 517, 520-21 (1996). 
254 Jurevic, supra note 248, at 241. 
255 Sidney D. Watson, Health Care in the Inner City: Asking the Right Question, 71 N.C. L. 
REv. 1647, 1669-70 (1993). 
256 Id. 
257 See id. 
258 Ian Ayres et ai., Unequal Racial Access to Kidney Transplantation, 46 VAND. L. REv. 805, 
859 (1993). 
259Id. at 859 n.248. 
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Title VI also allows private parties to file legal complaints alleging 
a Title VI violation.260 In response to racial discrimination in the 
health care sector, Title VI has been used by private plaintiffs in at-
tempts to prevent hospitals geographically situated in predominately 
African-American communities from closing or relocating to Euro-
pean-American neighborhoods.261 The Supreme Court has deter-
mined that Title VI applies when there is disproportionate adverse 
impact discrimination, without proof of intent to discriminate, so long 
as the plaintiff alleges a violation of Title VI's implementing regula-
tions. 262 In Alexander v. Clwate, the Supreme Court clarified what 
amounted to a confusing set of prior opinions on the issue of whether 
Title VI required purposeful discrimination.263 Here, the Court first 
held that Title VI, on its oum, apart from its implementing regulations, 
applies only to intentional discrimination.264 The Court went on to 
state, however, that Title VI plaintiffs can state a claim by showing dis-
proportionate adverse impact, without proof of intent to discriminate, 
as long as the plaintiff takes care to allege a violation of Title VI im-
plementing regulations.265 
The prima facie case for a Title VI claim involves three ele-
ments.266 First, there must be state action proved via federal financial 
assistance.267 Second, there must be an agency regulation that prohib-
its actions that have the effect of treating people of different races, 
colors or national origins differently.268 Third, there must be a dis-
proportionate effect on a particular race. 269 
If the plaintiff can successfully allege a prima facie case, the bur-
den shifts to the defendant.27o Once the burden shifts, the defendant 
260 Jurevic, supra note 248, at 24l. 
261 See Hampton, supra note 253, at 536-49; Sidney D. Watson, Reinvigorating Titk VI: 
Defending Health Care Discrimination-It Shouldn't Be So Easy, 58 FORDHAM L. REv. 939, 966-
71 (1990) [hereinafter Watson, Titk V1]. 
262 Alexander v. Choate, 469 U.S. 287, 293 (1985); Watson, Titk VI, supra note 261, at 
952-53. 
26' Choate, 469 U.S. at 293; see Guardians Ass'n v. Civil Servo Comm'n, 463 U.S. 582,584 
(1983). 
264 Choate, 469 U.S. at 293. 
265 Id. at 293-94. 
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must offer evidence to justify the unequal effect.271 Courts have been 
unclear as to whether, at this juncture in litigation, the burden shifts 
back to the plaintiff.272 Experts have suggested that Title VII case law 
should be used as a guide.273 Hence, under the Title VII model as ap-
plied to a Title VI lawsuit, if the defendant is able to present a valid 
justification, the burden should shift back to the plaintiff.274 At this 
stage, the plaintiff would need to demonstrate that a less discrimina-
tory alternative exists.275 Title VI claims have the potential to serve as 
a useful weapon in the battle against racial inequality in the allocation 
of transplantable organs.276 Within the area of racial discrimination in 
the distribution of organs for transplantation, it is conceivable that 
Title VI lawsuits could be brought against UNOS itself for failure to 
equitably allocate organs for transplantation and against individual 
hospitals for failure to place Mrican-American patients on UNOS or-
gan allocation waiting lists. 277 
It is likely that an Mrican-American plaintiff in a case brought 
against UNOS for failure to equitably distribute organs would be able 
to satisfy the prima facie elements of a Title VI claim.278 First, the fed-
eral financial assistance requirement is likely to be satisfied.279 UNOS 
operates under a government contract.280 More importantly, UNOS is 
the recipient of federal funding. 281 Based on these factors, a court is 
likely to hold that UNOS is a state actor.282 Second, the plaintiff would 
need to point to the Title VI implementing regulations that forbid 
organizations receiving federal funding (in this instance UNOS) from 
using "criteria or methods of administration which have the effect of 
subjecting individuals to discrimination because of their race, color, 
or national origin, or have the effect of defeating or substantially im-
pairing accomplishment of the objectives of the program as respect 
271 Jurevic, supra note 248, at 241. 
272 See Watson, Title VI, supra note 261, at 954. 
273 Id. at 955. 
274 See id. at 958. 
275 See id. 
276 See Ayres et ai., supra note 258, at 853-60. 
277Id. at 859; see Hampton, supra note 253, at 542-49. 
27B See Ayres et ai., supra note 258, at 855-59. 
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individuals of a particular race, color, or national origin. "283 Third, the 
Mrican-American plaintiff would need to establish that the UNOS 
guidelines for the allocation of kidneys have a discriminatory impact 
on African-Americans.284 The African-American plaintiff should focus 
on the fact that UNOS kidney allocation guidelines still place empha-
sis on antigen matching.285 Thus, European Americans receive a 
greater percentage of the kidneys available for transplantation.286 M-
ter the establishment of a prima facie case, the burden would shift to 
UNOS.287 In order to provide justification for the disparate impact on 
African Americans, UNOS would most likely try to persuade the court 
that antigen matching is essential for effective kidney transplanta-
tion.288 
Finally, if UNOS is successful in arguing the validity of antigen 
matching, the burden may shift back to the plaintiff.289 At this point 
the plaintiff would need to convince the court of the existence of 
equally effective, non-discriminatory alternatives to the current 
UNOS kidney allocation guidelines.290 Here, the plaintiff should ar-
gue that an organ allocation system which places even less emphasis 
on partial antigen matching and awards equitable points for the pres-
ence of uncommon antigens will promote greater racial equality 
without sacrificing overall effectiveness.291 During this final phase of 
litigation, the plaintiff should remind the court that Congress man-
dated that the allocation of organs be both efficient and equitable.292 
The less discriminatory alternative proposed by the plaintiff, an organ 
allocation system that places little emphasis of partial antigen 
matches, has the potential to realize both the efficiency and the equi-
table legislative mandates.293 
An African-American plaintiff may also be able to state a Title VI 
claim against a hospital that fails to place African Americans on 
283 45 C.F.R. § 80.3(b) (2) (1973). 
284 See Jurevic, supra note 248, at 241. 
285 Ayers et aI., supra note 258, at 855-56. 
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UNOS kidney allocation waiting lists.294 In such a case, the court 
would most likely find federal financial assistance because most hospi-
tals are the recipients of federal funding. 295 Second, the plaintiff 
should draw attention to the Title VI implementing regulations that 
forbid organizations receiving federal funding, in this instance the 
individual hospital, from using "criteria or methods of administration 
which have the effect of subjecting individuals to discrimination be-
cause of their race, color, or national origin. "296 Finally, the plaintiff 
would need to present evidence to prove that the hospital is in fact 
discriminating against Mrican Americans by failing to place Mrican 
Americans on UNOS kidney allocation waiting lists.297 
CONCLUSION 
At the dawn of the twenty-first century, racism continues to infect 
health care in the United States.298 Although blatant forms of racial 
discrimination have been eradicated, more subtle variations continue 
to make access to and delivery of health care dependent upon race.299 
Racial inequality is readily apparent in the allocation of transplantable 
kidneys.300 Despite having higher rates of kidney failure than Euro-
pean Americans, Mrican Americans are less likely to be the recipients 
of transplantable kidneys and spend considerably longer periods of 
time on kidney allocation waiting lists than European Americans.301 
In order to ameliorate racial inequality within the sphere of kid-
ney allocation a battle must be waged from various fronts. 302 With 
education, organ donation publicity campaigns and possibly the en-
actment of presumed consent statutes, the supply of transplantable 
organs has the potential to increase.303 The creation of UNOS organ 
allocation waiting list criteria and the 1995 alterations to UNOS allo-
294 See Hampton, supra note 253, at 543-49 (explaining recent cases brought against 
hospitals under Title Vl);jurevic, supra note 248, at 241. 
295 See Perkins, supra note 58, at 379. 
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298 See discussion supra Part I.C and notes 50-119. 
299 See discussion supra Parts I.B-C and notes 29-119. 
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cation guidelines have the potential to bring about increased racial 
equality.304 
If, however, racial parity remains an unachieved goal, UNOS 
must be forced to further revise waiting list criteria and allocation 
guidelines.305 It may also be possible to bring an Equal Protection suit 
against UNOS.306 Additionally, Title VI claims, filed against either 
UNOS or individual hospitals, have the potential to help eliminate 
racial disparity.307 Working in concert, these varied responses have the 
ability to bring about greater racial equality in the sphere of kidney 
allocation.308 
304 See discussion supra Parts IV.B-C and notes 218-29. 
305 See discussion supra Parts IV.B-C and notes 218-229. 
306 See discussion supra Part IV.D and notes 230-240. 
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